Jul 20, 2026 07:00AM
Jul 20, 2026 07:00AM
Jul 13, 2026 06:40AM
Jul 8, 2026 07:00AM
Jul 8, 2026 07:00AM
May 19, 2026 07:00AM
May 19, 2026 07:00AM OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD
Apr 29, 2026 07:00AM
Apr 7, 2026 09:43AM
Apr 7, 2026 07:00AM
Apr 7, 2026 07:00AM
Apr 7, 2026 07:00AM
Mar 18, 2026 07:00AM
Mar 18, 2026 07:00AM OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain
Feb 23, 2026 11:00AM
Feb 10, 2026 08:00AM
Feb 10, 2026 08:00AM
Jan 30, 2026 11:30AM
Jan 30, 2026 11:30AM
Jan 29, 2026 06:52AM
Jan 28, 2026 07:40AM OKYO Pharma receives FDA alignment on phase 2b/3 trial design
Jan 28, 2026 07:40AM
Jan 26, 2026 06:50AM
Jan 23, 2026 07:00AM
Jan 23, 2026 07:00AM
Jan 5, 2026 07:00AM
Jan 5, 2026 07:00AM
Dec 19, 2025 07:00AM OKYO Pharma to Ring the Opening Bell at Nasdaq
Dec 15, 2025 08:33AM
Dec 15, 2025 08:30AM
Dec 11, 2025 08:30AM
Dec 11, 2025 08:30AM
Dec 7, 2025 11:48PM
Dec 3, 2025 07:01AM
Dec 3, 2025 07:00AM OKYO Pharma Announces Chairman and Founder Acquires Shares
Nov 21, 2025 08:30AM
Nov 21, 2025 08:30AM
Nov 18, 2025 08:30AM
Oct 29, 2025 07:00AM
Oct 16, 2025 08:30AM
Oct 16, 2025 08:30AM
Sep 23, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)
Sep 22, 2025 08:35AM
Sep 22, 2025 08:30AM
Jul 17, 2025 09:00AM
Jul 17, 2025 09:00AM
Jul 17, 2025 06:50AM
Jul 16, 2025 09:21AM
Jul 16, 2025 09:21AM OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain
Jun 11, 2025 08:30AM

326,716 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All